Clinical Trials Logo

Muscular Dystrophy, Duchenne clinical trials

View clinical trials related to Muscular Dystrophy, Duchenne.

Filter by:
  • Completed  
  • Page 1 ·  Next »

NCT ID: NCT06379906 Completed - Clinical trials for Duchenne Muscular Dystrophy

Upper Extremity Muscle Strength, Balance and Functional Skills in DMD

Start date: November 10, 2023
Phase:
Study type: Observational [Patient Registry]

This study aims to examine the relationship between upper extremity muscle strength, balance and functional skills of children with DMD.

NCT ID: NCT06304064 Completed - Clinical trials for Duchenne Muscular Dystrophy

Halt cardiomyOPathy progrEssion in Duchenne (HOPE-OLE)

HOPE-OLE
Start date: June 21, 2018
Phase: Phase 2
Study type: Interventional

This Phase 2, multi-center, open-label extension trial will provide CAP-1002 to participants who were randomized to the Usual Care treatment group of the HOPE-Duchenne study (NCT02485938) and completed 12 months of follow-up. The trial will assess the safety and efficacy of two intravenous administrations of CAP-1002, each separated by three months.

NCT ID: NCT06186310 Completed - Clinical trials for Duchenne or Becker Muscular Dystrophy

Effectiveness of Aquatic Therapy in Children With Duchenne and Becker Muscular Dystrophy

Start date: November 5, 2023
Phase: N/A
Study type: Interventional

The purpose of this study is ; to evaluate the effects of aquatic therapy applied in addition to conventional physical therapy on balance, functionality and quality of life in children with Duchenne and Becker muscular dystrophy.

NCT ID: NCT06174025 Completed - Clinical trials for Duchenne Muscular Dystrophy

Validity and Reliability of the 6 Minute Pegboard Ring Test

Start date: June 30, 2023
Phase:
Study type: Observational

This study aimed to investigate the validity and reliability of 6PBRT in individuals with DMD and its applicability on these patients.

NCT ID: NCT06103006 Completed - Clinical trials for Duchenne Muscular Dystrophy

Remote Physiotherapy to Protect Physical Health in Duchenne Muscular Dystrophy

Start date: January 1, 2021
Phase: N/A
Study type: Interventional

Duchenne Muscular Dystrophy (DMD) is a progressive genetic neuromuscular disease characterized by progressive loss of motor function, respiratory failure, and cardiomyopathy required regular physiotherapy. With the outbreak of the pandemic rehabilitation centers that make up the weekly physiotherapy routine of children with disabilities have slowed down or even stopped their activities. So DMD who have additional diseases such as respiratory muscle weakness, spinal deformity, obesity, and cardiac dysfunction have also been negatively affected. The 'telerehabilitation' method, which is well planned and prepared for the abilities and needs of patients and caregivers, is seen as a good option at this point. Studies, reporting the feasibility and safety of telerehabilitation in joint replacement, multiple sclerosis, and post-operative conditions, report that the length of stay was reduced, there was access to the same level of service regardless of the distance, and there was no travel cost. Despite these advantages, the framework and applicability of telerehabilitation programs have been investigated limited and not focused on effectiveness of telerehabilitation in patients with DMD. According to the current knowledge, telerehabilitation in DMD is a subject that needs to be investigated in terms of its benefits. So, in this study, it was aimed to show the telerehabilitation's feasibility and its effects on performance level, endurance, fall frequency, pulmonary functions, and satisfaction level with the program in individuals with DMD.

NCT ID: NCT05990608 Completed - Clinical trials for Duchenne Muscular Dystrophy (DMD)

Peabody Developmental Motor Scaling In Children With Period Duchenne Muscular Dystrophy

Start date: July 30, 2021
Phase:
Study type: Observational

To perform the reliability and validity study of the Peabody Developmental Motor Scale (Peabody Developmental Motor Scales-2) in children with Duchenne Muscular Dystrophy (DMD).

NCT ID: NCT05688072 Completed - Clinical trials for Muscular Dystrophy, Duchenne Type

Trunk Oriented Exercises Versus Whole-body Vibration for Duchenne Muscular Dystrophy

Start date: January 15, 2023
Phase: N/A
Study type: Interventional

The abdominal muscles play an important role in stabilizing the trunk and providing postural stability. Children with Duchene muscular dystrophy have weak muscles, which may impair postural adjustments. These postural adjustments are required for gait and dynamic balance during the daily living activities.

NCT ID: NCT05657938 Completed - Clinical trials for Duchenne Muscular Dystrophy

Evaluation of Home Based Assessments on Participants With DMD

Start date: October 13, 2022
Phase:
Study type: Observational

This study is designed to evaluate the feasibility, wearability and participant satisfaction of novel outcome assessment tools in DMD patients which are performed in the home environment.

NCT ID: NCT05575648 Completed - Clinical trials for Duchenne Muscular Dystrophy

Dual Task in Duchenne Muscular Dystrophy

Start date: September 6, 2022
Phase: N/A
Study type: Interventional

This study was planned to determine the effects of the dual-task performance of children with DMD with motor dysfunction and varying degrees of cognitive impairment compared to their healthy peers, to compare the dual-task performance of children with different functional levels, and to determine the relationship between parameters that may affect dual-task performance.

NCT ID: NCT05564962 Completed - Clinical trials for Duchenne Muscular Dystrophy

Quality and Independence of Gait Classification Scale for DMD (QIGS-DMD)

Start date: January 19, 2021
Phase:
Study type: Observational

The aim of this study was to develop a reliable and valid gait classification scale for Duchenne Muscular Dystrophy (QIGS-DMD). The items of the QIGS-DMD were designed based on the literature review considering existing functional classification scales, gait scales, and the opinions of the physiotherapists who were expertized in rehabilitation of patients with DMD. Content validity was determined based on the opinions of a total of ten expert physiotherapists. Videos were recorded during gait of 69 children with DMD and inter- and intra-rater reliability were examined. Criterion validity was determined according to the relationship between QIGS-DMD and Motor Function Measure (MFM) and Vignos Lower Extremity Rating Scale (VLERS).